China (Mainland)
Regorafenib hydrochloride CAS NO.835621-07-3
- Min.Order: 1 Gram
- Payment Terms: T/T
- Product Details
Keywords
- Regorafenib hydrochloride 835621-07-3
- 835621-07-3 producer
- 835621-07-3 seller
Quick Details
- ProName: Regorafenib hydrochloride
- CasNo: 835621-07-3
- Molecular Formula: C21H15ClF4N4O3.ClH
- Application: only for research
- DeliveryTime: 2 weeks
- PackAge: according to the request of customer
- Port: Ji nan;
- ProductionCapacity: 1 Kilogram/Month
- Purity: 99%
- Storage: Low temperature dry and shady
- Transportation: according to the request of customer
- LimitNum: 1 Gram
Superiority
We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway inhibitors,
pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom synthesis, transfer of new
drug patent and technology, technical cooperation, and process optimization.
Details
Year Establishment: 2008
Location: At one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City
Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business
management experts
We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies
since the foundation
Specifications:
Name Regorafenib hydrochloride
Synonyms 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrochloride
Molecular Formula C21H15ClF4N4O3.HCl
Molecular Weight 519.28
CAS Registry Number 835621-07-3
Applications:
Regorafenib hydrochloride is the intermediate of BAY 73-4506 (Regorafenib), which is a multikinase inhibitwith IC50 of 17, 40 69 nM c-KIT, VEGFR2, B-Raf.
